Monday, November 6, 2000
Aclara BioSciences Inc. may have taken blows in its trade secret
litigation and separate patent infringement suit with Caliper Technologies Corp. But
regardless of the eventual outcome of the litigation, ACLA believes it will not be left
without a business.
Last week, a California Superior Court jury awarded $52.6 million to
CALP in a 1999 lawsuit in which the company charged that its trade secrets had been used
by ACLA to apply for U.S. Patent No. 5,750,015 covering methods and devices for moving
molecules via the application of electric fields (see BioCentury Extra, Monday Oct.